BVXP Bioventix Plc

TIDMBVXP

RNS Number : 0811W

BioVentix PLC

07 December 2023

Bioventix plc

("Bioventix" or the "Company")

Result of AGM

Bioventix plc (AIM: BVXP) a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that at its Annual General Meeting held earlier today, all resolutions put to shareholders were duly passed.

For further information please contact:

 
 Bioventix plc                                        Tel: 01252 728 001 
  Peter Harrison            Chief Executive Officer 
  Bruce Hiscock             Chief Financial Officer 
 
 finnCap Ltd                                          Tel: 020 7220 0500 
  Geoff Nash / Simon        Corporate Finance 
  Hicks                     ECM 
  Nigel Birks / Harriet 
  Ward 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGBUBDDUDGDGXR

(END) Dow Jones Newswires

December 07, 2023 10:26 ET (15:26 GMT)

Bioventix (LSE:BVXP)
Historical Stock Chart
From Mar 2024 to Apr 2024

Bioventix (LSE:BVXP)
Historical Stock Chart
From Apr 2023 to Apr 2024